Filtered By:
Drug: Methotrexate
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 4930 results found since Jan 2013.
Subcutaneous panniculitis-like T-cell lymphoma presenting as facial infiltration with long-term response to methotrexate: Two cases
Ann Dermatol Venereol. 2023 Jul 12:S0151-9638(23)00061-3. doi: 10.1016/j.annder.2023.04.003. Online ahead of print.NO ABSTRACTPMID:37442745 | DOI:10.1016/j.annder.2023.04.003
Source: Annales de Dermatologie et de Cenereologie - July 13, 2023 Category: Dermatology Authors: D Marc é D Canu C Laurent C Pottier M-L Jullie T Kervarrec M Beylot-Barry M Samimi Source Type: research
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
CONCLUSIONS: Our review shows that, compared to placebo, the biologics infliximab, bimekizumab, ixekizumab, and risankizumab were the most effective treatments for achieving PASI 90 in people with moderate-to-severe psoriasis on the basis of high-certainty evidence. This NMA evidence is limited to induction therapy (outcomes measured from 8 to 24 weeks after randomisation), and is not sufficient for evaluating longer-term outcomes in this chronic disease. Moreover, we found low numbers of studies for some of the interventions, and the young age (mean 44.6 years) and high level of disease severity (PASI 20.4 at baseline) ma...
Source: Cochrane Database of Systematic Reviews - July 12, 2023 Category: General Medicine Authors: Emilie Sbidian Anna Chaimani Robin Guelimi Ignacio Garcia-Doval Camille Hua Carolyn Hughes Luigi Naldi Maria Kinberger Sivem Afach Laurence Le Cleach Source Type: research
Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)
CONCLUSION: Our work has shown a similar AE profile of csDMARDs to previous data. However, higher discontinuation rates for SSZ and LEF cannot be explained easily from AE profiles.PMID:37431434 | PMC:PMC10329773 | DOI:10.1093/rap/rkad053
Source: Adv Data - July 11, 2023 Category: Epidemiology Authors: Pawel Mielnik Joseph Sexton Karen M Fagerli Gunnstein Bakland Yi Hu Eirik K Kristianslund Mari Hoff Ada Wier ød Tore K Kvien Source Type: research
